- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01605968
A Comparative Efficacy and Safety Study Between Two Silver Containing Dressings In Post-Op Wound Healing
July 12, 2017 updated by: Bio-medical Carbon Technology Co., Ltd.
A Comparative Efficacy and Safety Study Between BCT Silver Bandage and Aquacel® Ag. Dressing In Obstetrical and Gynecological Post-Op Wound Healing
Study objective:
The objective of this study is to evaluate through clinical criteria the clinical efficacy and safety of BCT Silver Bandage role in obstetrical and gynecological wound healing is as effective and safe as Aquacel® Ag. Dressing.
Study devices:
- Study device: BCT Silver Bandage
- Comparator device:"ConvaTec"Aquacel® Ag Hydrofiber Dressing
Study design:
- Randomized, Open-label, interventional, comparative, preventive study with Blinded evaluator.
- All subjects must meet all the inclusion & exclusion criteria to enter this study in pre-operative phase.
- Eligible subjects will be enrolled after a scheduled operative procedure.
- There is SEVEN visits in this study (one screening eligibility phase up to 7 days before OP day, and four post-op treatment scheduled visits consisting on 1st , 3rd day, 5th day, 12th day and two follow up visit on the 28th and the 42nd post-operative day.
- During each scheduled visit, each subject will have colored picture of his wound after dressing been removed, and on visit V6 for wound evaluation by blinded PI.
Number of subjects: It is expected to recruit ≧150 eligible subjects.
Study Duration: About eighteen month.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
38
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taichung City, Taiwan, 40201
- Dep. of Gynecology and Obstetrics, Chung-Shan Medical University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Male/Female of any race aged between 18 - 70 years old
- The subject is willing and able to understand, sign and date the study Informed Consent, and be able to adhere to the scheduled visits regimen.
- The subject is having surgery (Cesarean pfannenstiel or Open Laparotomy incision) within 1 week
Exclusion Criteria:
- Patients with known allergy or topical hypersensitivity to ionic silver or alginate
- Any systemic or local active dermatological disease that might interfere with the evaluation of the surgical site such as eczema, psoriasis, skin cancer, scleroderma, chronic urticarial
- Patients undergoing MRI (Magnetic Resonance Imaging) examination.
- Subject residence is outside the study center city
- Patients was participating in another clinical trial less than 30 days before participation in this trial
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: BCT Silver Bandage
|
Activated carbon fiber impregnated with silver particles
|
Active Comparator: Aquacel® Ag. Dressing
|
Antimicrobial primary dressing incorporating the unique gelling action of Hydrofiber® Technology with ionic silver for wounds that are infected or at risk of infection.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Efficacy measurements
Time Frame: 42 days after operation
|
|
42 days after operation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Safety Measurement
Time Frame: 42 days after operation
|
The incidence of postoperative skin reactions (defined as blisters, itching, erythematous change around the surgical wound site) within 5 days after operation
|
42 days after operation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Chih-Jen Tseng, MD, Dep. of Gynecology and Obstetrics, Chung-Shan Medical University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2012
Primary Completion (Actual)
October 1, 2013
Study Completion (Actual)
January 1, 2014
Study Registration Dates
First Submitted
May 23, 2012
First Submitted That Met QC Criteria
May 24, 2012
First Posted (Estimate)
May 25, 2012
Study Record Updates
Last Update Posted (Actual)
July 14, 2017
Last Update Submitted That Met QC Criteria
July 12, 2017
Last Verified
July 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CS11176
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgical Wound
-
St. Borbala HospitalSemmelweis University; Department of Surgery, Jahn Ferend Dél-Pesti Kórház... and other collaboratorsTerminatedSurgical Wound | Surgical Site Infection | Wound Dehiscence, Surgical | Dehiscence of Internal Surgical WoundHungary
-
ConvaTec Inc.Not yet recruitingSurgical Wound, Recent | Trauma-related Wound | Dehiscence Wound | Surgical Wound LeakUnited States
-
Centro Hospitalar do Tâmega e SousaActive, not recruitingSurgical Wound | Surgical Wound Infection | Surgical Site Infection | Surgical Wound, Healed | Surgical Complication | Surgical Wound Dehiscence | Surgical Wound HaemorrhagePortugal
-
Molnlycke Health Care ABSyntactxNot yet recruitingSurgical Wound | Surgical Incision | Surgical Wound Dehiscence | Incision, Surgical | Surgical Wound, Recent
-
Associazione Infermieristica per lo studio delle...Unknown
-
Brock Liden, DPMWithdrawnSurgical Wound, HealedUnited States
-
University of California, DavisCompletedSurgical Wound Cosmesis
-
Biointelligent Technology Systems SLUniversidad Pública de Navarra; Dasman Diabetes InstituteRecruitingWounds and Injuries | Wound Surgical | Wound Healing DisorderSpain
-
HITEC-Institute of Medical SciencesCompletedWound Infection | Wound Dehiscence | Wound Surgical | Wound BleedingPakistan
-
Abouqir General HospitalAlexandria UniversityCompletedSurgical Wound Closure TechniqueEgypt
Clinical Trials on BCT Silver Bandage
-
Bio-Cancer Treatment International LimitedThe University of Hong KongTerminated
-
University of ArizonaNational Cancer Institute (NCI); National Institutes of Health (NIH)Not yet recruitingBreast CancerUnited States
-
Bio-medical Carbon Technology Co., Ltd.National Taiwan University HospitalCompleted
-
Bio-medical Carbon Technology Co., Ltd.National Taiwan University HospitalCompleted
-
Regen Lab SACompleted
-
Bio-Cancer Treatment International LimitedUnknownAcute Myeloid LeukemiaHong Kong
-
Medical University of ViennaOutcomes Research ConsortiumTerminated
-
University Hospital, ToulouseRecruiting
-
Universidade Norte do ParanáCompleted
-
Johnson & Johnson Consumer Inc. (J&JCI)CompletedWound HealingUnited States